108 related articles for article (PubMed ID: 25378636)
1. HIV Nef promotes expression of B-lymphocyte stimulator by blood dendritic cells during HIV infection in humans.
Chagnon-Choquet J; Gauvin J; Roger J; Fontaine J; Poudrier J; Roger M;
J Infect Dis; 2015 Apr; 211(8):1229-40. PubMed ID: 25378636
[TBL] [Abstract][Full Text] [Related]
2. High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans.
Fontaine J; Chagnon-Choquet J; Valcke HS; Poudrier J; Roger M;
Blood; 2011 Jan; 117(1):145-55. PubMed ID: 20870901
[TBL] [Abstract][Full Text] [Related]
3. High expression levels of BLyS/BAFF by blood dendritic cells and granulocytes are associated with B-cell dysregulation in SIV-infected rhesus macaques.
Poudrier J; Soulas C; Chagnon-Choquet J; Burdo T; Autissier P; Oskar K; Williams KC; Roger M
PLoS One; 2015; 10(6):e0131513. PubMed ID: 26107380
[TBL] [Abstract][Full Text] [Related]
4. Blood B Lymphocyte Stimulator (BLyS)/BAFF levels may reflect natural immunity to HIV in highly exposed uninfected Beninese Commercial Sex Workers.
Sabourin-Poirier C; Fourcade L; Chagnon-Choquet J; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
Sci Rep; 2016 Aug; 6():32318. PubMed ID: 27561453
[TBL] [Abstract][Full Text] [Related]
5. HIV-1-Mediated BAFF Secretion in Macrophages Does Not Require Endosomal TLRs, Type-I IFN, and Nef, but Depends on the Cellular Phenotype Status.
Gomez AM; Ouellet M; Deshiere A; Breton Y; Tremblay MJ
J Immunol; 2016 May; 196(9):3806-17. PubMed ID: 27022194
[TBL] [Abstract][Full Text] [Related]
6. Alterations in B Cell Compartment Correlate with Poor Neutralization Response and Disease Progression in HIV-1 Infected Children.
Aggarwal H; Khan L; Chaudhary O; Kumar S; Makhdoomi MA; Singh R; Sharma K; Mishra N; Lodha R; Srinivas M; Das BK; Kabra SK; Luthra K
Front Immunol; 2017; 8():1697. PubMed ID: 29250072
[TBL] [Abstract][Full Text] [Related]
7. Fluctuations in Blood Marginal Zone B-Cell Frequencies May Reflect Migratory Patterns Associated with HIV-1 Disease Progression Status.
Gauvin J; Chagnon-Choquet J; Poudrier J; Roger M;
PLoS One; 2016; 11(5):e0155868. PubMed ID: 27203285
[TBL] [Abstract][Full Text] [Related]
8. HIV Nef expression favors the relative preservation of CD4+ T regulatory cells that retain some important suppressive functions.
Chrobak P; Afkhami S; Priceputu E; Poudrier J; Meunier C; Hanna Z; Sparwasser T; Jolicoeur P
J Immunol; 2014 Feb; 192(4):1681-92. PubMed ID: 24465014
[TBL] [Abstract][Full Text] [Related]
9. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
López P; Scheel-Toellner D; Rodríguez-Carrio J; Caminal-Montero L; Gordon C; Suárez A
Rheumatology (Oxford); 2014 Dec; 53(12):2249-58. PubMed ID: 24942493
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion.
Quaranta MG; Mattioli B; Giordani L; Viora M
FASEB J; 2004 Sep; 18(12):1459-61. PubMed ID: 15240562
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Nef Protein Affects Cytokine and Extracellular Vesicles Production in the GEN2.2 Plasmacytoid Dendritic Cell Line.
Aiello A; Giannessi F; Percario ZA; Fecchi K; Arenaccio C; Leone S; Carollo M; D'Aversa E; Chaperot L; Gambari R; Sargiacomo M; Affabris E
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062278
[TBL] [Abstract][Full Text] [Related]
12. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
[TBL] [Abstract][Full Text] [Related]
13. Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes.
Petit C; Buseyne F; Boccaccio C; Abastado JP; Heard JM; Schwartz O
Virology; 2001 Jul; 286(1):225-36. PubMed ID: 11448175
[TBL] [Abstract][Full Text] [Related]
14. Intracellular overexpression of HIV-1 Nef impairs differentiation and maturation of monocytic precursors towards dendritic cells.
Guo Y; Xu WW; Song J; Deng W; Liu DQ; Zhang HT
PLoS One; 2012; 7(7):e40179. PubMed ID: 22808111
[TBL] [Abstract][Full Text] [Related]
15. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.
Moir S; Malaspina A; Pickeral OK; Donoghue ET; Vasquez J; Miller NJ; Krishnan SR; Planta MA; Turney JF; Justement JS; Kottilil S; Dybul M; Mican JM; Kovacs C; Chun TW; Birse CE; Fauci AS
J Exp Med; 2004 Sep; 200(5):587-99. PubMed ID: 15353552
[TBL] [Abstract][Full Text] [Related]
16. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
17. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
Azad AA
Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
[TBL] [Abstract][Full Text] [Related]
18. Plasmacytoid dendritic cells and myeloid cells differently contribute to B-cell-activating factor belonging to the tumor necrosis factor superfamily overexpression during primary HIV infection.
Borhis G; Burelout C; Chaoul N; Smith N; Goujard C; Meyer L; Paul S; Saoudin H; Hosmalin A; Gilbert C; Herbeuval JP; Richard Y
AIDS; 2016 Jan; 30(3):365-76. PubMed ID: 26558721
[TBL] [Abstract][Full Text] [Related]
19. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients.
Stohl W; Cheema GS; Briggs WS; Xu D; Sosnovtseva S; Roschke V; Ferrara DE; Labat K; Sattler FR; Pierangeli SS; Hilbert DM
Clin Immunol; 2002 Aug; 104(2):115-22. PubMed ID: 12165272
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.
de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA
AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
